FMO5 and chronic granulomatous disease: Consistent with these findings, patients with chronic granulomatous diseases that lacks functional NADPH oxidase exhibit increased neutrophil viability (Fadeel et al., 1998) and reduced neutrophil apoptosis following ingestion of bacteria (Coxon et al., 1996).